IL101290A - Vaccines for the treatment of herpes simplex virus infections - Google Patents
Vaccines for the treatment of herpes simplex virus infectionsInfo
- Publication number
- IL101290A IL101290A IL10129092A IL10129092A IL101290A IL 101290 A IL101290 A IL 101290A IL 10129092 A IL10129092 A IL 10129092A IL 10129092 A IL10129092 A IL 10129092A IL 101290 A IL101290 A IL 101290A
- Authority
- IL
- Israel
- Prior art keywords
- rgd2t
- alum
- mpl
- hsv
- glycoprotein
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9105992A GB9105992D0 (en) | 1991-03-21 | 1991-03-21 | Vaccine |
Publications (2)
Publication Number | Publication Date |
---|---|
IL101290A0 IL101290A0 (en) | 1992-11-15 |
IL101290A true IL101290A (en) | 1996-07-23 |
Family
ID=10691946
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL10129092A IL101290A (en) | 1991-03-21 | 1992-03-19 | Vaccines for the treatment of herpes simplex virus infections |
Country Status (34)
Country | Link |
---|---|
US (1) | US6027730A (fr) |
EP (1) | EP0576478B2 (fr) |
JP (1) | JP3530526B2 (fr) |
KR (1) | KR100224329B1 (fr) |
CN (2) | CN1058191C (fr) |
AP (1) | AP298A (fr) |
AT (1) | ATE129160T1 (fr) |
AU (1) | AU650521B2 (fr) |
BR (1) | BR9205745A (fr) |
CA (1) | CA2106492C (fr) |
CY (1) | CY1936A (fr) |
CZ (1) | CZ280505B6 (fr) |
DE (1) | DE69205566T3 (fr) |
DK (1) | DK0576478T4 (fr) |
ES (1) | ES2081102T5 (fr) |
FI (1) | FI107881B (fr) |
GB (1) | GB9105992D0 (fr) |
GR (1) | GR3017884T3 (fr) |
HK (1) | HK1004525A1 (fr) |
HU (1) | HU218025B (fr) |
IE (1) | IE69560B1 (fr) |
IL (1) | IL101290A (fr) |
MA (1) | MA22471A1 (fr) |
MX (1) | MX9201245A (fr) |
MY (1) | MY110086A (fr) |
NO (1) | NO307499B1 (fr) |
NZ (1) | NZ242057A (fr) |
PL (1) | PL170059B1 (fr) |
PT (1) | PT100262B (fr) |
SA (1) | SA92120459B1 (fr) |
SK (1) | SK279190B6 (fr) |
WO (1) | WO1992016231A1 (fr) |
YU (1) | YU28392A (fr) |
ZA (1) | ZA922011B (fr) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9105992D0 (en) * | 1991-03-21 | 1991-05-08 | Smithkline Beecham Biolog | Vaccine |
US6197311B1 (en) | 1991-07-25 | 2001-03-06 | Idec Pharmaceuticals Corporation | Induction of cytotoxic T-lymphocyte responses |
GB9202933D0 (en) * | 1992-02-12 | 1992-03-25 | Smithkline Beecham Biolog | Vaccines |
US6620414B2 (en) | 1992-03-27 | 2003-09-16 | Smithkline Beecham Biologicals (S.A.) | Hepatitis vaccines containing 3-0-deacylated monophoshoryl lipid A |
EP0684838A1 (fr) * | 1993-02-19 | 1995-12-06 | Smithkline Beecham Corporation | Compositions de vaccin contre la grippe, contenant un lipide a de monophosphoryle desacyle en position 3-o |
EP1175912A1 (fr) * | 1993-03-23 | 2002-01-30 | SmithKline Beecham Biologics SA | Compositions vaccinales renfermant le lipide à monophosphorylique 3-O désacétylé |
DK0705109T4 (da) * | 1993-05-25 | 2004-05-10 | Wyeth Corp | Adjuvanser til vacciner mod respiratorisk syncytialvirus |
GB9326253D0 (en) * | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
ES2196098T3 (es) | 1994-12-28 | 2003-12-16 | Univ Kentucky Res Found | Secuencias anticuerpos anti-idiotipo 3h1 monoclonales relacionadas con el antigeno carcinoembrionico humano. |
US6949244B1 (en) | 1995-12-20 | 2005-09-27 | The Board Of Trustees Of The University Of Kentucky | Murine monoclonal anti-idiotype antibody 11D10 and methods of use thereof |
US6235280B1 (en) | 1996-04-12 | 2001-05-22 | Malaya Chatterjee | Methods of delaying development of CEA-associated tumors using anti-idiotype antibody 3H1 |
US20020041872A1 (en) | 1996-04-12 | 2002-04-11 | Malaya Chatterjee | Methods of delaying development of CEA-associated tumors using anti-idiotype antibody 3H1 |
US6468782B1 (en) | 1996-12-05 | 2002-10-22 | Quadrant Healthcare (Uk) Limited | Methods of preserving prokaryotic cells and compositions obtained thereby |
US6274143B1 (en) | 1997-06-13 | 2001-08-14 | Malaya Chatterjee | Methods of delaying development of HMFG-associated tumors using anti-idiotype antibody 11D10 |
US6355244B1 (en) | 1997-11-17 | 2002-03-12 | University Of Kentucky Research Foundation | Methods and compositions for the treatment of psoriasis |
GB9819898D0 (en) * | 1998-09-11 | 1998-11-04 | Smithkline Beecham Plc | New vaccine and method of use |
US6692752B1 (en) | 1999-09-08 | 2004-02-17 | Smithkline Beecham Biologicals S.A. | Methods of treating human females susceptible to HSV infection |
ES2284287T3 (es) | 1998-10-16 | 2007-11-01 | Glaxosmithkline Biologicals S.A. | Sistemas adyuvantes y vacunas. |
US7026155B2 (en) | 1999-02-02 | 2006-04-11 | Regents Of The University Of California | Method of reducing bacterial proliferation |
EP1104767A1 (fr) | 1999-11-30 | 2001-06-06 | Stichting Dienst Landbouwkundig Onderzoek | Dérivés de mono- et disaccharides contenant esters d'acides gras et esters de sulfate |
US9273326B2 (en) | 2004-04-30 | 2016-03-01 | The Brigham And Women's Hospital, Inc. | Tetracycline-regulated gene expression in HSV-1 vectors |
ES2472441T3 (es) | 2004-09-22 | 2014-07-01 | Glaxosmithkline Biologicals S.A. | Composición inmunog�nica para uso en vacunación contra estafilococos |
AR052625A1 (es) | 2005-03-23 | 2007-03-21 | Glaxosmithkline Biolog Sa | Nueva composicion |
GB0607088D0 (en) | 2006-04-07 | 2006-05-17 | Glaxosmithkline Biolog Sa | Vaccine |
PT3017827T (pt) | 2005-12-22 | 2019-01-28 | Glaxosmithkline Biologicals Sa | Vacina conjugada polissacarídica pneumocócica |
MY148405A (en) | 2006-03-30 | 2013-04-30 | Glaxosmithkline Biolog Sa | Immunogenic composition |
MX2009000660A (es) | 2006-07-17 | 2009-04-08 | Glaxosmithkline Biolog Sa | Vacuna de influenza. |
US20090181078A1 (en) * | 2006-09-26 | 2009-07-16 | Infectious Disease Research Institute | Vaccine composition containing synthetic adjuvant |
CA2662921C (fr) | 2006-09-26 | 2018-11-20 | Infectious Disease Research Institute | Vaccin, compositions pharmaceutiques, necessaires et utilisations de ceux-ci pour stimuler une reponse immunitaire avec un adjuvant glucopyranosyl lipide synthetique |
AR066405A1 (es) | 2007-04-20 | 2009-08-19 | Glaxosmithkline Biolog Sa | Vacuna |
RS54349B1 (en) | 2007-06-26 | 2016-02-29 | Glaxosmithkline Biologicals S.A. | VACCINE CONTAINING STREPTOCOCCUS PNEUMONIAE Capsular POLYSACCHARIDE CONJUGATES |
BRPI1012811A2 (pt) | 2009-05-22 | 2016-03-29 | Genocea Biosciences Inc | vacinas contra o vírus herpes simplex tipo 2: composições e métodos para obtenção de uma resposta imune |
WO2010141861A1 (fr) * | 2009-06-05 | 2010-12-09 | Infectious Disease Research Institute | Adjuvants lipidiques synthétiques à base de glucopyranosyle |
GB0913680D0 (en) | 2009-08-05 | 2009-09-16 | Glaxosmithkline Biolog Sa | Immunogenic composition |
GB0913681D0 (en) | 2009-08-05 | 2009-09-16 | Glaxosmithkline Biolog Sa | Immunogenic composition |
HUE029564T2 (en) | 2009-12-21 | 2017-03-28 | Brigham & Womens Hospital Inc | Herpes simplex virus vaccines |
JP6055776B2 (ja) | 2010-11-24 | 2016-12-27 | ジェノセア バイオサイエンシーズ, インコーポレイテッド | 単純ヘルペスウイルス2型に対するワクチン:免疫応答を誘発する組成物及び方法 |
CN103619350A (zh) * | 2011-03-11 | 2014-03-05 | 麦克马斯特大学 | 包含组蛋白去乙酰化酶抑制剂的疫苗接种方法 |
SG194083A1 (en) | 2011-04-08 | 2013-11-29 | Immune Design Corp | Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses |
WO2013028738A1 (fr) | 2011-08-22 | 2013-02-28 | Nanobio Corporation | Vaccin contre le virus de l'herpès simplex sous forme de nanoémulsion |
WO2013078299A1 (fr) | 2011-11-23 | 2013-05-30 | Genocea Biosciences, Inc. | Vaccins à acide nucléique contre le virus d'herpès simplex de type 2 : compositions et procédés pour susciter une réponse immunitaire |
WO2013173590A1 (fr) | 2012-05-16 | 2013-11-21 | Immune Design Corp. | Vaccins contre le hsv-2 |
EP2941269B1 (fr) | 2013-01-07 | 2020-12-09 | Mucosal Vaccine Technologies LLC | Vaccins thérapeutiques permettant de traiter les infections par le virus de l'herpès simplex de type 2 |
EA032326B1 (ru) | 2013-04-18 | 2019-05-31 | Иммьюн Дизайн Корп. | Монотерапия gla для применения в лечении рака |
US9463198B2 (en) | 2013-06-04 | 2016-10-11 | Infectious Disease Research Institute | Compositions and methods for reducing or preventing metastasis |
WO2018064232A1 (fr) | 2016-09-28 | 2018-04-05 | Genocea Biosciences, Inc. | Méthodes et compositions pour le traitement d'herpès |
US11390650B2 (en) | 2018-02-05 | 2022-07-19 | The Brigham And Women's Hospital, Inc. | Recombinant Herpes Simplex Virus-2 expressing glycoprotein B and D antigens |
AU2022208435A1 (en) | 2021-01-18 | 2023-08-10 | Conserv Bioscience Limited | Coronavirus immunogenic compositions, methods and uses thereof |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4372945A (en) * | 1979-11-13 | 1983-02-08 | Likhite Vilas V | Antigen compounds |
IL61904A (en) * | 1981-01-13 | 1985-07-31 | Yeda Res & Dev | Synthetic vaccine against influenza virus infections comprising a synthetic peptide and process for producing same |
US5110587A (en) * | 1981-12-24 | 1992-05-05 | Health Research, Incorporated | Immunogenic composition comprising synthetically modified vaccinia virus |
US5149660A (en) * | 1982-02-18 | 1992-09-22 | University Patents, Inc. | Diagnostic reagents relating to herpes simplex virus |
US4762708A (en) * | 1982-02-18 | 1988-08-09 | University Patents, Inc. | Materials and methods for herpes simplex virus vaccination |
NZ209308A (en) * | 1983-08-30 | 1991-08-27 | Genentech Inc | Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein |
US5171568A (en) * | 1984-04-06 | 1992-12-15 | Chiron Corporation | Recombinant herpes simplex gb-gd vaccine |
US5244792A (en) * | 1984-04-06 | 1993-09-14 | Chiron Corporation | Expression of recombinant glyoprotein B from herpes simplex virus |
US4877611A (en) * | 1986-04-15 | 1989-10-31 | Ribi Immunochem Research Inc. | Vaccine containing tumor antigens and adjuvants |
US5554372A (en) * | 1986-09-22 | 1996-09-10 | Emory University | Methods and vaccines comprising surface-active copolymers |
ATE136468T1 (de) * | 1986-10-20 | 1996-04-15 | Chiron Corp | Impfstoff zur behandlung von hsv |
US5149529A (en) * | 1988-04-08 | 1992-09-22 | Board Of Trustees Of Leland Chiron Corporation | Compositions and treatment for herpes simplex |
US4912094B1 (en) * | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
NZ230424A (en) * | 1988-08-25 | 1992-05-26 | Liposome Co Inc | Liposomal composition comprising an externally disposed antigen |
EP0440742B1 (fr) * | 1988-10-27 | 1997-01-15 | The Regents Of The University Of Minnesota | Immunoadjuvants liposomiques contenant de l'il-2 |
US5597573A (en) * | 1989-05-04 | 1997-01-28 | Igen, Inc. | Lipid-A analogs: new monosaccharide and disaccharide intermediates for eliciting therapeutic antibodies and for antitumor and antiviral activities |
US5158939A (en) * | 1989-07-21 | 1992-10-27 | Wisconsin Alumni Research Foundation | Method of stimulating the immune systems of animals and compositions useful therefor |
AU651949B2 (en) * | 1989-07-14 | 1994-08-11 | American Cyanamid Company | Cytokine and hormone carriers for conjugate vaccines |
ES2144400T3 (es) * | 1990-08-01 | 2000-06-16 | Res Corp Technologies Inc | Gen que codifica la gliproteina d del virus del herpes equino de tipo 1, su producto genico, anticuerpos y su utilizacion. |
ATE179614T1 (de) * | 1990-08-02 | 1999-05-15 | Chiron Corp | Herpes simplex virus vp16 impfstoffe |
GB9106048D0 (en) * | 1991-03-21 | 1991-05-08 | Smithkline Beecham Biolog | Vaccines |
US5196452A (en) * | 1991-01-29 | 1993-03-23 | Genelabs Incorporated | Macrocyclic anti-viral compound and method |
US5166173A (en) * | 1991-01-29 | 1992-11-24 | Genelabs Incorporated | Method of treating herpes simplex virus infection |
GB9105992D0 (en) * | 1991-03-21 | 1991-05-08 | Smithkline Beecham Biolog | Vaccine |
MY111880A (en) * | 1992-03-27 | 2001-02-28 | Smithkline Beecham Biologicals S A | Hepatitis vaccines containing 3-0 deacylated monophosphoryl lipid a |
CA2138997C (fr) * | 1992-06-25 | 2003-06-03 | Jean-Paul Prieels | Composition vaccinale qui contient des adjuvants |
EP0684838A1 (fr) * | 1993-02-19 | 1995-12-06 | Smithkline Beecham Corporation | Compositions de vaccin contre la grippe, contenant un lipide a de monophosphoryle desacyle en position 3-o |
EP1175912A1 (fr) * | 1993-03-23 | 2002-01-30 | SmithKline Beecham Biologics SA | Compositions vaccinales renfermant le lipide à monophosphorylique 3-O désacétylé |
DK0705109T4 (da) * | 1993-05-25 | 2004-05-10 | Wyeth Corp | Adjuvanser til vacciner mod respiratorisk syncytialvirus |
-
1991
- 1991-03-21 GB GB9105992A patent/GB9105992D0/en active Pending
-
1992
- 1992-03-17 JP JP50598492A patent/JP3530526B2/ja not_active Expired - Lifetime
- 1992-03-17 SK SK946-93A patent/SK279190B6/sk unknown
- 1992-03-17 KR KR1019930702835A patent/KR100224329B1/ko not_active IP Right Cessation
- 1992-03-17 PL PL92300617A patent/PL170059B1/pl unknown
- 1992-03-17 AU AU13657/92A patent/AU650521B2/en not_active Expired
- 1992-03-17 HU HU9302645A patent/HU218025B/hu unknown
- 1992-03-17 CY CY193692A patent/CY1936A/xx unknown
- 1992-03-17 DK DK92906441T patent/DK0576478T4/da active
- 1992-03-17 CZ CS931958A patent/CZ280505B6/cs not_active IP Right Cessation
- 1992-03-17 DE DE69205566T patent/DE69205566T3/de not_active Expired - Lifetime
- 1992-03-17 BR BR9205745A patent/BR9205745A/pt not_active Application Discontinuation
- 1992-03-17 EP EP19920906441 patent/EP0576478B2/fr not_active Expired - Lifetime
- 1992-03-17 ES ES92906441T patent/ES2081102T5/es not_active Expired - Lifetime
- 1992-03-17 WO PCT/EP1992/000592 patent/WO1992016231A1/fr active IP Right Grant
- 1992-03-17 AT AT92906441T patent/ATE129160T1/de active
- 1992-03-17 CA CA 2106492 patent/CA2106492C/fr not_active Expired - Lifetime
- 1992-03-18 MY MYPI92000448A patent/MY110086A/en unknown
- 1992-03-19 NZ NZ242057A patent/NZ242057A/en not_active IP Right Cessation
- 1992-03-19 CN CN92102950A patent/CN1058191C/zh not_active Expired - Lifetime
- 1992-03-19 IE IE920881A patent/IE69560B1/en not_active IP Right Cessation
- 1992-03-19 PT PT100262A patent/PT100262B/pt not_active IP Right Cessation
- 1992-03-19 MA MA22760A patent/MA22471A1/fr unknown
- 1992-03-19 IL IL10129092A patent/IL101290A/en not_active IP Right Cessation
- 1992-03-19 ZA ZA922011A patent/ZA922011B/xx unknown
- 1992-03-20 YU YU28392A patent/YU28392A/sh unknown
- 1992-03-20 AP APAP/P/1992/000368A patent/AP298A/en active
- 1992-03-20 MX MX9201245A patent/MX9201245A/es unknown
- 1992-04-21 SA SA92120459A patent/SA92120459B1/ar unknown
-
1993
- 1993-09-20 NO NO933343A patent/NO307499B1/no not_active IP Right Cessation
- 1993-09-21 FI FI934134A patent/FI107881B/fi not_active IP Right Cessation
-
1994
- 1994-09-09 US US08/303,542 patent/US6027730A/en not_active Expired - Lifetime
-
1995
- 1995-10-25 GR GR950402992T patent/GR3017884T3/el unknown
-
1998
- 1998-01-05 CN CN98103933A patent/CN1101226C/zh not_active Expired - Lifetime
- 1998-04-28 HK HK98103623A patent/HK1004525A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0576478B1 (fr) | Vaccin de l'herpes simplex comprenant une glycoproteine gd du hsv et le lipide a de monophosphoryle 3-deacyle | |
JP4510283B2 (ja) | 併合ワクチン組成物 | |
CA2217178C (fr) | Vaccins contenant une saponine ainsi qu'un sterol | |
US5776468A (en) | Vaccine compositions containing 3-0 deacylated monophosphoryl lipid A | |
CA2384064C (fr) | Vaccin contre le virus herpes simplex et le papillomavirus humain | |
US6846489B1 (en) | Vaccines containing a saponin and a sterol | |
AU7284800A (en) | Novel composition | |
AU2003236490B2 (en) | Novel composition | |
MXPA00008817A (en) | Combined vaccine compositions | |
BRPI0017420B1 (pt) | Composição de vacina, hpv 16 l1 e hpv 18 l1 vpl | |
MXPA97008226A (es) | Vacunas que contienen una saponina y un esterol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
EXP | Patent expired |